392 material Form 8-K filings that 341 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Aflac reported second-quarter 2024 net earnings of $1.8 billion, or $3.10 per diluted share, up from $2.71 a year earlier, while total revenues fell 0.7% to $5.1 billion. Adjusted earnings per diluted share rose 15.8% to $1.83, and the board declared a $0.50 third-quarter dividend. Shareholders benefit from higher profit per share and $800 million in share repurchases, though the company's net earnings included $696 million in net investment gains.
Net earnings $1.8 billion, or $3.10 per diluted share, vs. $2.71 a year ago
Total revenues $5.1 billion, vs. $5.2 billion in Q2 2023
Adjusted earnings per diluted share $1.83, up 15.8%; net investment gains of $696 million included in net earnings
$800 million used to repurchase 9.3 million shares; third-quarter dividend of $0.50 per share payable September 2, 2024
Host Hotels & Resorts reported second-quarter 2024 revenue of $1.466 billion, up 5.2%, and net income of $242 million, up 13.1%, with diluted EPS of $0.34 versus $0.29. The company lowered its full-year 2024 guidance, citing a slower Maui recovery and moderating leisure demand, which lowers the midpoints of net income and Adjusted EBITDAre for shareholders.
Q2 2024 revenue was $1.466 billion, up 5.2%, and comparable hotel RevPAR rose 0.1%.
Q2 net income was $242 million, up 13.1%, helped by $53 million more in insurance settlement gains than in Q2 2023.
Full-year 2024 net income guidance is $683 million to $741 million, a $35 million cut at the midpoint versus the prior range of $719 million to $775 million.
Full-year 2024 diluted EPS guidance is $0.95 to $1.03, down $0.05 at the midpoint from $1.00 to $1.08.
Service Corporation International reported second quarter 2024 revenue of $1,034.0 million, up $20.6 million from a year earlier, but diluted earnings per share fell to $0.81 from $0.86. The company said full-year 2024 adjusted earnings per share will likely be at the lower end of its $3.50 to $3.80 guidance range because funeral services performed fell below expectations, while it kept its operating cash flow guidance midpoint.
Q2 2024 revenue $1,034.0 million vs. $1,013.4 million in Q2 2023
Diluted EPS $0.81 vs. $0.86; adjusted EPS $0.79 vs. $0.83
2024 adjusted EPS now expected at lower end of $3.50 to $3.80 range; prior guidance unchanged
Net cash from operating activities $196.9 million vs. $144.1 million a year earlier
Eversource Energy reported second-quarter 2024 GAAP earnings of $335.3 million, or $0.95 per share, up from $15.4 million, or $0.04 per share, a year earlier. The prior-year period included a $331.0 million impairment of its offshore wind investment, and operating revenues fell to $2.53 billion from $2.63 billion. The company reaffirmed its 2024 non-GAAP earnings projection of $4.50 to $4.67 per share, and said it closed the Sunrise Wind sale and expects to close the Revolution and South Fork Wind sales later this quarter.
Q2 2024 GAAP EPS was $0.95 ($335.3 million) versus $0.04 ($15.4 million) in Q2 2023, which included a $331.0 million offshore wind impairment.
Excluding charges, Q2 EPS was $0.95 in 2024 versus $1.00 in 2023, according to the earnings slides.
Operating revenues were $2.53 billion for the quarter, compared with $2.63 billion a year earlier.
The 2024 non-GAAP EPS projection of $4.50 to $4.67 was reaffirmed; a webcast with management is set for August 1, 2024.
Park Hotels & Resorts reported second-quarter 2024 net income of $67 million, compared with a net loss of $146 million a year earlier, when results included a $203 million impairment and casualty loss. Total revenues fell 4.0% to $686 million, and the company lowered the midpoint of its full-year 2024 Comparable RevPAR growth outlook, while its diluted EPS outlook midpoint rose slightly.
Q2 2024 diluted EPS was $0.30, versus a loss of $0.70 in Q2 2023; Q2 total revenues fell 4.0% to $686 million.
Comparable RevPAR rose 2.0% to $194.90 in Q2 2024.
Full-year 2024 Comparable RevPAR change outlook is now 3.5% to 4.5%, down from 4.0% to 5.5%; diluted EPS outlook is $0.69 to $0.83, versus $0.66 to $0.85 previously.
Board declared a $0.25 per share Q3 2024 dividend payable October 15, 2024; the company repurchased about 1.7 million shares for $25 million in June 2024.
Kyndryl reported first-quarter fiscal 2025 revenue of $3.74 billion, down 11% year over year, as it reduced low-margin third-party content in customer contracts. Net income was $11 million, or $0.05 per diluted share, compared with a net loss of $141 million a year earlier, and the company raised its fiscal 2025 adjusted pretax income and adjusted EBITDA margin outlook while reaffirming its constant-currency revenue decline outlook of (2%) to (4%).
Revenue of $3.74 billion, down 11% year over year and 8% in constant currency
Net income of $11 million, or $0.05 per diluted share, versus a net loss of $141 million a year earlier; adjusted pretax income of $92 million, up 96%
Adjusted pretax income outlook for fiscal 2025 raised to at least $460 million from at least $435 million
Constant-currency revenue outlook of (2%) to (4%) reaffirmed; company expects year-over-year revenue growth in the fourth quarter
Genworth Financial reported second-quarter 2024 results on July 31, 2024. Net income available to common stockholders was $76 million, or $0.17 per diluted share, down from $139 million in the prior quarter, while adjusted operating income rose to $125 million, or $0.28 per diluted share, from $85 million. The mixed picture matters to shareholders because GAAP profit fell while the company's non-GAAP measure improved, and the results were driven by Enact and offset by losses in long-term care insurance and net investment losses.
Net income available to common stockholders was $76 million ($0.17 per diluted share) in Q2 2024, versus $139 million in Q1 2024.
Adjusted operating income was $125 million ($0.28 per diluted share), versus $85 million in Q1 2024 and $85 million in Q2 2023.
Net investment losses, net of taxes, reduced net income by $48 million in the quarter.
Company repurchased $36 million of common stock in the quarter; $111 million executed year-to-date through July 31, 2024.
Innoviva reported second quarter 2024 results on July 31, 2024. Total revenue rose to $99.9 million from $81.0 million a year earlier, but the company posted a net loss of $34.7 million, or $(0.55) per share, compared with net income of $1.3 million, or $0.02 per share, in the second quarter of 2023. The company attributed the loss mainly to unfavorable changes in the fair value of its equity and long-term investments, primarily from a lower share price of Armata Pharmaceuticals.
Total revenue was $99.9 million versus $81.0 million in Q2 2023; net product sales were $21.7 million, up from $15.7 million.
Net loss was $34.7 million, or $(0.55) per share, versus net income of $1.3 million, or $0.02 per share, a year earlier.
Unfavorable fair value change in equity and long-term investments was $90.7 million, mainly from lower Armata Pharmaceuticals share price.
Gross royalty revenue from GSK was $67.2 million, and the company completed its $100 million share repurchase program during the quarter.
Employers Holdings reported second quarter 2024 results, with net income per diluted share of $1.25 versus $1.30 a year earlier and adjusted net income per diluted share of $1.10 versus $1.17. Net premiums earned rose 6% to $187.8 million, but the GAAP combined ratio worsened to 94.2% from 90.4%, so headline profit fell while revenue grew. The board also declared a regular quarterly dividend of $0.30 per share.
Net income per diluted share $1.25 vs $1.30; adjusted net income per diluted share $1.10 vs $1.17
Net premiums earned $187.8 million, up 6%; GAAP combined ratio 94.2% vs 90.4%
Quarterly dividend of $0.30 per share, payable August 28, 2024, to holders of record as of August 14, 2024
Repurchased 461,789 shares in Q2 2024 at an average $41.53; $44.4 million remaining authorization
Axcelis reported second quarter 2024 revenue of $256.5 million, up from $252.4 million in the first quarter, and net income of $50.9 million, or $1.55 per diluted share, down from $1.57 in the first quarter. For the third quarter, the company expects revenue of approximately $255 million and diluted EPS of approximately $1.43, both below second quarter results. Second quarter revenue was also below the $274.0 million reported a year earlier, and diluted EPS was down from $1.86.
Q2 2024 revenue of $256.5 million, compared with $252.4 million in Q1 2024 and $274.0 million in Q2 2023
Operating profit of $52.8 million, compared with $56.5 million in Q1 2024 and $63.7 million in Q2 2023
Q3 2024 outlook: revenue of approximately $255 million and diluted EPS of approximately $1.43
Company says Q2 revenue, operating margin and EPS exceeded its guidance for the period
Glaukos reported second-quarter 2024 net sales of $95.7 million, up 19% from a year earlier, and raised its full-year 2024 net sales guidance to $370 million to $376 million from $357 million to $365 million. GAAP net loss widened to $53.9 million, or $1.06 per diluted share, from $32.8 million, or $0.68 per share, a year earlier, including an $18.0 million charge tied to convertible senior note exchanges.
Q2 2024 net sales of $95.7 million, up from $80.4 million in Q2 2023
GAAP net loss of $53.9 million, or $1.06 per diluted share, versus $32.8 million, or $0.68, in Q2 2023
2024 net sales guidance raised to $370 million to $376 million from $357 million to $365 million
$18.0 million charges associated with convertible senior notes; cash and investments of $266.4 million as of June 30, 2024
Independence Realty Trust reported second quarter 2024 results on July 31, 2024, with diluted EPS of $0.05, the same as a year earlier, and net income available to common shares of $10.4 million versus $10.7 million. The company raised the midpoint of its full-year 2024 EPS, FFO, CFFO per share and same-store NOI guidance, which matters to shareholders because it lifts the company's own outlook even though reported Q2 profit was flat.
Q2 2024 net income available to common shares was $10.4 million, versus $10.7 million in Q2 2023; diluted EPS was $0.05 in both periods.
CFFO was $63.6 million, or $0.28 per share, versus $63.7 million and $0.28 per share a year earlier.
2024 EPS guidance is now $0.36 to $0.38, up from $0.34 to $0.38; the midpoint rose $0.01.
Same-store NOI grew 2.8% in Q2 2024; full-year same-store NOI growth guidance is now 2.7% to 3.7%, up from 1.0% to 4.0%.
Knowles reported second-quarter 2024 revenue of $204.7 million, up 18% from a year earlier, with non-GAAP diluted EPS of $0.24. GAAP results were a diluted loss of $2.90 per share, driven by a $249.4 million goodwill impairment charge tied to the Consumer MEMS Microphones reporting unit. For shareholders, the revenue growth and third-quarter outlook sit alongside a large GAAP loss from the impairment.
Q2 2024 revenue was $204.7 million, up 18% from $173.0 million in Q2 2023 and up from $196.4 million in Q1 2024.
GAAP diluted loss per share was $(2.90), compared with $0.15 in Q2 2023; the goodwill impairment accounted for $2.77 per share.
Non-GAAP diluted EPS was $0.24, versus $0.23 a year earlier; net cash from operating activities was $24.9 million.
Q3 2024 guidance: revenue of $210 to $220 million and non-GAAP diluted EPS of $0.29 to $0.33.
Cognizant reported second-quarter 2024 revenue of $4.85 billion, down 0.7% from $4.89 billion a year earlier, but above the high end of its guidance range. GAAP diluted EPS rose to $1.14 from $0.91, and the company narrowed its full-year 2024 revenue guidance to a decline of 0.5% to growth of 1.0% in constant currency. The company also signed a definitive agreement to acquire Belcan for $1.3 billion in cash and stock.
Q2 2024 revenue of $4.85 billion, down 0.7% year over year; GAAP operating margin 14.6% vs 11.8% a year earlier
GAAP diluted EPS $1.14 vs $0.91; adjusted diluted EPS $1.17 vs $1.10
Full-year 2024 adjusted EPS guidance of $4.62 to $4.70; adjusted operating margin guidance unchanged at 15.3% to 15.5%
Belcan acquisition for $1.3 billion in cash and stock, expected to close in Q3 2024; quarterly dividend of $0.30 per share declared
LXP Industrial Trust reported second quarter 2024 results. Total gross revenues fell to $85.8 million from $87.1 million a year earlier, mainly due to property sales, while net income attributable to common shareholders was $3.8 million, or $0.01 per diluted share, compared with a loss a year earlier. Adjusted Company FFO declined to $46.9 million, or $0.16 per diluted share, from $52.7 million, or $0.18, and the company narrowed its 2024 Adjusted Company FFO guidance to $0.62 to $0.65 per diluted share.
Total gross revenues were $85.8 million, versus $87.1 million for the quarter ended June 30, 2023, which the company attributed mainly to property sales and lower other revenue.
Net income attributable to common shareholders was $3.8 million, or $0.01 per diluted share, versus a loss of $(9.7) million, or $(0.03) per diluted share, a year earlier.
Adjusted Company FFO was $46.9 million, or $0.16 per diluted share, versus $52.7 million, or $0.18 per diluted share, a year earlier.
For 2024, the company estimates net income attributable to common shareholders of $0.10 to $0.13 per diluted share and tightened its Adjusted Company FFO range to $0.62 to $0.65 per diluted share.
Penske Automotive Group reported second quarter 2024 revenue up 3% from a year earlier to a record $7.7 billion. Net income attributable to common stockholders fell 19.8% to $241.2 million, and earnings per share fell to $3.61 from $4.41, so profit declined even as sales grew. The board also approved a quarterly dividend of $1.07 per share, an 11% increase.
Revenue rose 3% to $7.7 billion, a quarterly record, versus $7.5 billion in Q2 2023.
Net income attributable to common stockholders was $241.2 million versus $300.8 million; EPS was $3.61 versus $4.41.
Quarterly dividend raised 11% to $1.07 per share, payable September 4, 2024, to holders of record as of August 15, 2024.
Graham Holdings reported second-quarter 2024 revenue of $1,185.3 million, up 7% from a year earlier, led by education, healthcare and automotive. It swung to a net loss attributable to common shareholders of $21.0 million ($4.79 per share), compared with income of $122.8 million ($25.89 per share) in the second quarter of 2023, mainly due to $26.3 million of goodwill and intangible asset impairment charges at World of Good Brands and a $73.5 million interest expense tied to a fair value adjustment. Excluding these and other listed items, adjusted net income was $56.9 million ($12.70 per share), down from $61.1 million ($12.88 per share).
Revenue: $1,185.3 million, up 7% from $1,105.0 million in Q2 2023
Operating income: $25.9 million, down from $58.1 million, due to impairment charges at World of Good Brands
Net loss attributable to common shareholders: $21.0 million ($4.79 per share), versus income of $122.8 million ($25.89 per share) a year earlier
Adjusted net income (non-GAAP): $56.9 million ($12.70 per share), versus $61.1 million ($12.88 per share)
BorgWarner reported second-quarter 2024 net sales of $3.6 billion, down 2% from a year earlier, while GAAP diluted EPS rose to $1.39 from $0.97 and adjusted EPS rose to $1.19 from $1.06. For full-year 2024, the company cut its net sales guidance to $14.1 billion to $14.4 billion from $14.4 billion to $14.9 billion, but raised its adjusted operating margin and adjusted EPS guidance.
Q2 2024 net sales were $3,603 million, down 2% from $3,671 million; organic sales fell 0.3%.
Full-year net sales guidance cut to $14.1 billion to $14.4 billion from $14.4 billion to $14.9 billion, citing lower market production and weaker foreign currencies.
Adjusted EPS guidance raised to $3.95 to $4.15 from $3.80 to $4.15; adjusted operating margin guidance raised to 9.6% to 9.8% from 9.2% to 9.6%.
Company plans to repurchase $300 million of shares in the second half of 2024 and announced a restructuring of its ePropulsion segment with about $100 million in annual savings expected by 2026.
Oshkosh reported second-quarter 2024 net sales of $2.85 billion, up 18.0%, driven by organic volume, the AeroTech acquisition and pricing. GAAP diluted earnings per share fell to $2.56 from $2.67 after $51.6 million of intangible asset impairments in the Defense segment, while adjusted EPS rose to $3.34 from $2.74. The company lowered its 2024 GAAP EPS outlook to $10.45 from $10.55 and raised its adjusted EPS outlook to $11.75 from $11.25.
Q2 net sales $2.85 billion, up 18.0%; GAAP net income $168.6 million versus $175.0 million a year earlier
GAAP diluted EPS $2.56 versus $2.67; adjusted EPS $3.34 versus $2.74
Gates Industrial reported second-quarter 2024 net sales of $885.5 million, down 5.4% from the prior year, while net income attributable to shareholders rose to $70.7 million, or $0.26 per diluted share, from $64.9 million, or $0.23. The company trimmed its 2024 guidance for core sales, adjusted EBITDA and adjusted EPS, and authorized a new $250 million share repurchase program valid through December 2025.
Q2 net sales $885.5 million, down 5.4%; core sales declined 4.0%
Net income attributable to shareholders $70.7 million, or $0.26 per diluted share, versus $0.23 a year earlier; adjusted EPS $0.36 versus $0.34
Adjusted EBITDA guidance lowered to $740 million to $770 million from $745 million to $805 million; adjusted EPS guidance to $1.29 to $1.35 from $1.28 to $1.43
New $250 million share repurchase authorization, valid through December 2025, replacing one set to expire in October 2024
Macerich reported second-quarter 2024 results. Net income attributable to the company was $252.0 million, or $1.16 per diluted share, versus a $15.0 million loss a year earlier, driven by a $325.0 million gain on sale or write-down of assets. Core FFO excluding certain items fell slightly to $0.39 per share from $0.40, and the company has not issued 2024 guidance since withdrawing it on April 30, 2024.
Total revenues were $215.5 million, up from $212.4 million in the second quarter of 2023.
Net income attributable to the company was $252.0 million, or $1.16 per diluted share, compared with a loss of $15.0 million, or $0.07 per share, a year earlier.
FFO excluding certain items was $88.1 million, or $0.39 per share, compared with $89.1 million, or $0.40 per share, in the prior-year quarter.
The company withdrew its 2024 guidance on April 30, 2024 and is not providing an updated outlook.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.